StockData
Legend Biotech Corp logo

Legend Biotech Corp (LEGN) stock

LEGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 10, 2026Score 3/30
$16.25+0.14 (+0.87%)

Close on Nov 18, 2026Market cap $3.01BP/E –Yield –

Legend Biotech profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Legend Biotech's profit margin for the twelve months ending Mar 31, 2025 was -30.0%. For fiscal 2024 it was -28.2%, against -181.8% the year before. The highest annual figure on record is -5.7% in fiscal 2018.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-28.2%+153.6
FY2023Dec 31, 2023-181.8%+199.7
FY2022Dec 31, 2022-381.5%+204.9
FY2021Dec 31, 2021-586.4%−231.2
FY2020Dec 31, 2020-355.2%−185.8
FY2019Dec 31, 2019-169.4%−163.7
FY2018Dec 31, 2018-5.7%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2025Mar 31, 2025-51.8%+11.9
Q4 FY2024Dec 31, 202414.1%+196.4
Q3 FY2024Sep 30, 2024-78.2%−13.4
Q2 FY2024Jun 30, 2024-9.8%+261.8
Q1 FY2024Mar 31, 2024-63.6%+244.9
Q4 FY2023Dec 31, 2023-182.3%+309.4
Q3 FY2023Sep 30, 2023-64.8%+245.7
Q2 FY2023Jun 30, 2023-271.6%–
Q1 FY2023Mar 31, 2023-308.5%–
Q4 FY2022Dec 31, 2022-491.7%–
Q3 FY2022Sep 30, 2022-310.5%–

More Legend Biotech figures

See a number that looks wrong?